• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Canada·Healthcare·CBDY
Share

Target Group Inc. Stocks

$ 0Last Updated 26.10.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 617026

$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Target Group Inc. operates within the Canadian cannabis sector, managing the entire lifecycle from cultivation and processing to the distribution of carefully selected cannabis products for both adult medical and recreational consumers. Their extensive product portfolio encompasses traditional cannabis flower, vaporizer-compatible extract pods, and pre-rolls. They also offer a diverse array of innovative infused products, including K-cup compatible coffee and tea pods, beverages, edibles, and topical applications, in addition to a line of CBD wellness items. A notable proprietary product is "Wisp," a unique single-use, pre-measured pod and vaporizer system designed for consumers seeking to vaporize natural botanical herbs, including cannabis. Target Group holds a collaborative agreement with cGreen, Inc. for the manufacturing and distribution of "True Focus," a patent-pending THC antidote, across the United States, Europe, and the Caribbean regions. Further expanding its reach, the company also maintains distribution, collaboration, and licensing arrangements with Serious Seeds B.V. Originally incorporated in 2013, the entity underwent a name change from Chess Supersite Corporation to Target Group Inc. in July 2018. Its operational base is situated in Hamilton, Canada.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is overvalued on EV/EBITDA, underpriced on P/FC.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.10.2026 13:34

Outflows from tech stocks, a rocky start, and market distortions: Why Anthropic’s IPO Is Risky

27.10.2026 13:07

Hot Dogs vs. Squid. Will Netflix Save Its Business With a New Strategy?

27.10.2026 12:01

Top Stories This Morning: Intel to Acquire Quantum Startup, DoorDash in Talks for a $17 Billion Deal

27.10.2026 11:18

Stocks in South Korea and Japan surged on news of Anthropic's IPO. Is it time to buy?

27.10.2026 09:01

Anthropic's need for capital is growing. Will it receive an investment rating?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026